Skip to content

Iron Deficiency Anemia, Intravenous Iron Treatment

Intravenous Ferric Carboxymaltose vs Intravenous Iron Sucrose in Iron Deficiency Anemia â?? A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047607
Enrollment
50
Registered
2022-11-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E611- Iron deficiency

Interventions

Intervention1: Intravenous Ferric Carboxymaltose: After taking the consent and diagnosis of Iron Deficiency Anemia. Patients will be randomly allocated based on SNOSE technique into two groups. One g

Sponsors

JIPMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Age >18 years who are diagnosed to have iron deficiency anemia, Hb <7g% and admitted in medicine department in JIPMER

Exclusion criteria

Exclusion criteria: Exclusion Criteria 1. Pregnant female 2. Previous history of allergic reaction to IV iron preparations 3. Patient having Hb >= 7g% Hb. 4. Patients having S. Ferritin more than 30ng/ml with an exception to CKD patients. 5. Any active infections,sepsis 6. Ishchemic heart disease 7. Dimorphic anemia 8. Anemic patients with cardiac failure 9. Past history of blood transfusion within past one month 10. Patient with acute GI bleed or any active bleed 11. CKD with Increased ferritin( >500ng/ml) 12. Thalassemia 13. Not willing to give consent

Design outcomes

Primary

MeasureTime frame
hemoglobin, iron stores (Ferritin).Timepoint: Baseline,2,4,6th week

Secondary

MeasureTime frame
1. To determine the adverse events of both IV preparations. 2. To study the degree of variation in RBC indices at the end of 4,6th weeks.Timepoint: At 4,6th weeks

Countries

India

Contacts

Public ContactSUMANTH H S

JIPMER

pkbala77@gmail.com8012344492

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026